Results 61 to 70 of about 900,428 (163)

Cost-effectiveness of glaucoma management with monotherapy medications in Egypt

Journal of Advanced Pharmaceutical Technology & Research, 2017
Glaucoma is a serious chronic ophthalmic disease since it causes irreversible visual disability if untreated can lead to blindness. Treatment options include medications (classified into five major classes of drugs which are muscarinic cholinergic ...
Amal Abd-Elaal El-Khamery, Amir Ibrahim Mohamed, Hassan Eisa Hassan Swify, Alaa Ibrahim Mohamed   +3 more
doaj   +1 more source

Effect of adrenergic antagonists on epinephrine-induced uptake of I-PGUS across the BBB.

, 2015
Upper panel shows that more general alpha, alpha1, and alpha2 antagonists but not beta antagonists blocked epinephrine’s effect. Lower panel shows results that the highly selective alpha1 adrenergic receptor antagonist benoxathian but not the highly ...
William S. Sly (358930), William A Banks (823528), Shinya Dohgu (285633), Akihiko Urayama (823526), Sandra M. Robinson (318408), Jeffery H. Grubb (486973)   +5 more
core   +1 more source

Betabloqueador tópico pode determinar resultados inconclusivos no ecocardiograma sob estresse com dobutamina em pacientes com glaucoma Topical betablocker use can result in inconclusive dobutamine stress echocardiography in patients with glaucoma

Arquivos Brasileiros de Cardiologia, 2007
O ecocardiograma sob estresse com dobutamina é um método bem estabelecido para avaliar doença arterial coronária, cuja sensibilidade tem sido potencializada pela adição de atropina no final do protocolo.
Adriana Cordovil, Fernando Q. Matos, Orlando Campos Filho, Augusto Paranhos Jr., Ana Clara T. Rodrigues, Márcia V. Albernaz, Angelo A. V. de Paola, Antonio Carlos C. Carvalho   +7 more
doaj   +1 more source

Circannual variation in the expression of beta 2-adrenoceptors on human peripheral mononuclear leukocytes (MNLs) [PDF]

, 1988
Peripheral mononuclear leukocytes (MNLs) are widely used as a tissue model in studies of beta-adrenoceptor disturbances in hypertension and asthmatic diseases.
Remien, J., I. Langenmayer, Haen, Ekkehard, Liebl, B., J. Remien, Haen, E., Pangerl, A., Langenmayer, Irmgard, B. Liebl, E. Haen, Langenmayer, I., A. Pangerl   +11 more
core   +1 more source

Medical treatment of female overactive bladder syndrome and treatment-related effects

Journal of the Formosan Medical Association, 2018
The age-adjusted prevalence of overactive bladder syndrome (OAB) in Taiwan is approximately 16.9%. Currently, a variety of treatments are available for female OAB.
Sheng-Mou Hsiao, Ho-Hsiung Lin
doaj   +1 more source

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A., Russell, J.A., Rankin, A.C., Norrie, J., Workman, A.J.   +4 more
core   +1 more source

Effects of full and partial β-adrenergic agonists and antagonists on human lung adenylate cyclas

, 1983
The beta-adrenergic stimulation of adenylate cyclase in membranes from human lung was compared to that of adenylate cyclase in membranes with a majority of beta 2-adrenergic receptors (from rat lung) and in membranes with a homogeneous population of beta
Delhaye, Myriam, Christophe, Jean, Chatelain, Pierre, Waelbroeck, Magali, Taton, Gérard, Robberecht, Patrick, Camus, Jean Claude   +6 more
core   +1 more source

Frequency of coprescription and potential risk of bronchospasm in Colombian patients users of topical antiglaucomatous betablockers and bronchodilators

Vitae, 2014
Background: Cardiovascular and respiratory effects of adrenergic agonists used in diseases like chronic obstructive pulmonary disease (COPD), and β-blockers used in glaucoma generate competitive antagonism on the same adrenergic receptor when used ...
Jorge Enrique Machado-Alba, Valentina Hoyos-Soto   +1 more
doaj  

Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors.

, 1988
The beta 1- and beta 2-adrenergic receptors are two structurally related, but pharmacologically distinguishable, receptor subtypes, both of which activate adenylyl cyclase in a catecholamine-dependent manner through the guanine nucleotide-binding ...
Daniel, KW, Lefkowitz, RJ, Frielle, T, Caron, MG   +3 more
core   +1 more source

New onset bronchial asthma following oral propranolol for infantile hemangioma

Respiratory Medicine Case Reports
Propranolol, a nonselective adrenergic beta-receptor blocker, is the first-line drug used for the treatment of infantile hemangiomas (IH). However, its use is contraindicated in patients with bronchial asthma.
Yuki Yamaguchi, Satoshi Horino, Hiroki Miyabayashi, Haruka Aki, Katsushi Miura   +4 more
doaj   +1 more source